STAT+: Biotech accelerator Curie.Bio extends its reach with new $380 million fund
Industry veterans Alexis Borisy and Zach Weinberg had plenty of reasons to celebrate their new…
Category: Medicine
Opinion: AI and rural health care: A paradigm shift in America’s heartland
The use of artificial intelligence is happening in “unlikely places.” So says a recent working…
STAT+: Q&A: How Flagship’s Cellarity is using AI to understand cell disease biology before treating it
Flagship Pioneering launched Cellarity in December 2019. The startup says it’s using artificial intelligence and…
Three months into bird flu outbreak in U.S. dairy cows, experts see deep-rooted problems in response
Three months since an outbreak of avian influenza in U.S. dairy cattle was declared, the…
Opinion: FDA: Don’t rush publishing your diversity guidance plan. Take your time and do it right
When Congress passed the Food and Drug Omnibus Reform Act (FDORA) in December 2022, it…
Opinion: Listen: Rep. Diana DeGette on why reproductive freedom must be protected
It has been two years since the Supreme Court made the historic decision to overturn…
.jpg)
Michigan launches first effort of its kind to detect silent bird flu infections in farmworkers
Michigan has led the nation in making inroads with its farmers as it has worked…
Journals issue corrections noting vaping researchers’ undisclosed ties to Juul
WASHINGTON — A journal published by the American Medical Association has corrected four articles from…
Opinion: CNN debate moderators could provide the cognitive tests that Biden and Trump have been avoiding
The two primary contenders for the presidency of the United States — President Joe Biden…
Stop blindly allowing MA plans to use AI to deny care, lawmakers urge Biden administration
A bipartisan group of lawmakers is urging the Biden administration to prohibit Medicare Advantage insurers…
Standalone organ donor centers have sprouted all over the U.S. Do they work better than hospitals?
Not much sets the world of transplant medicine abuzz. But in the early 2000s, a…
Senators push Medicare for a PET scan pay bump
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Can screening for food insecurity make a difference for patients? The jury is out
When you get sick, your path to wellness depends on more than your health care….
One firm, two conflicting takes on Alnylam’s HELIOS-B
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Opinion: Tackling administrative harm can yield better decisions for better care
Awareness of the harms to patients caused by errors in diagnosis and treatment has been…
STAT+: Pharmalittle: We’re reading about Novo’s Wegovy approval in China, a Merck KGaA cancer trial failure, and more
Top of the morning to you, and a fine one it is. Clear blue skies…
WHO warns global health toll of alcohol remains ‘unacceptably high’
The global health toll of alcohol remains “unacceptably high” across the globe, the World Health…
STAT+: U.K. pharma increasingly violates voluntary industry marketing codes, and probes are taking longer
Pharmaceutical companies in the U.K. have increasingly violated a voluntary industry marketing code but complaints…
Surgeon general declares gun violence a public health crisis
Firearm violence is officially a public health crisis in the U.S. — Surgeon General Vivek…
STAT+: Former Moderna executive launches genome editing company
As chief medical officer of Moderna, Tal Zaks used to be skeptical of genome editing….
STAT+: AliveCor gets FDA nod for portable 12-lead, AI-powered ECG device
AliveCor has spent years battling with Apple over the market for consumer heart monitoring technology….
Opinion: Could billions of dollars in AI funding lead to the same number of new drugs?
Drug discovery has quickly become the most enticing place to apply artificial intelligence. Billions of…
Opinion: Turning a ‘no’ vote into progress: How to advance MDMA-assisted psychotherapy for PTSD
Many people have interpreted as a setback the “no” vote by an advisory committee to…
.jpg)
The 42 best books and podcasts on health and science to check out this summer
Summer is officially here, and whether you’re relaxing in the great outdoors or riding out…
STAT+: Experts split on whether Eli Lilly’s Zepbound will hamper CPAP sales
Continuous positive airway pressure “is here to stay,” sleep medicine doctor Atul Malhotra declared in…
Despite risks, aspirin use remains high among older adults
New research shows that, in spite of recommendations discouraging use of aspirin in primary prevention…
STAT+: Grail, aiming to launch a blood test for cancer, faces host of challenges as it debuts on Nasdaq
On Tuesday, shares of Grail, the liquid biopsy company that hopes that its test, Galleri,…
STAT+: HHS finalizes penalties for providers resorting to ‘information blocking’
The federal government has cemented a key part of its strategy for making patients’ medical…
Infant deaths increased after Texas banned abortion in early pregnancy
Since Texas’s ban on abortion went into effect, infant deaths in the state increased by…
STAT+: Oral ketamine tablets effective for treating depression, new study finds
The results of a randomized controlled trial published Monday showed oral ketamine tablets were safe…
The Supreme Court will consider state bans on gender-affirming care for minors
WASHINGTON — The Supreme Court on Monday jumped into the fight over transgender rights, agreeing to…
STAT+: Steward Health Care executives are mired in trouble at home. In Malta, it’s much worse
VALLETTA, Malta — The most sweeping corruption trial in the history of this Mediterranean country…
STAT+: Pharmalittle: We’re reading about a plan for Medicare coverage of Wegovy, an Alnylam heart drug, and more
Good morning, everyone, to another working week. We hope the weekend respite was relaxing and…
The findings from Alnylam’s highly anticipated readout
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Alnylam reports positive results for heart drug in pivotal study, likely clearing path to approval
Alnylam Pharmaceuticals said Monday that its treatment for an increasingly common heart condition cut the…
Bird flu snapshot: USDA secretary urges farmers to take protective measures
Bird flu snapshot: This is the second installment in a series of regular updates on…
STAT+: Ateev Mehrotra, the researcher the telehealth lobby loves to hate, isn’t backing down
WASHINGTON — He hardly seems the part of the telehealth industry’s public enemy No. 1….
STAT+: How the medical device tracking director at Kaiser Permanente weeds out risky devices
When a new medical device hits the market, there’s typically still some uncertainty about whether…
Opinion: Two years since Dobbs, reproductive freedom must be protected from assault
It’s been two years since America’s highest court removed a constitutional right — for the…
Opinion: To reduce suicide, primary care and mental health clinicians need to work together. Congress can help that happen
Suicide rates in the United States increased approximately 36% between 2000 and 2022, according to…
Opinion: The FDA needs to embrace phage therapy to help fight antimicrobial resistance
My daughter, Mallory, died in 2017 at the age of 25 from a multiply resistant…
Hank Green on his ‘Pissing Out Cancer’ comedy special, ulcerative colitis, and the jokes that got cut
There’s a website dedicated to asking how many days it’s been since Hank Green started…
Opinion: Readers respond to essays on long Covid, hypochondria, and more
First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the…
STAT+: The CEO of Kaiser’s new health network shares why he’s making a bet on a tiny North Carolina hospital system
Outside of North Carolina, most people probably haven’t heard of Cone Health. But the relatively…
STAT+: Jury orders Stanford to pay millions to employee in racial harassment case
A jury has found Stanford University and Stanford Health Care liable for millions of dollars…
STAT+: Vertex reports positive results in stem cell trial for type 1 diabetes
ORLANDO — Twelve people with type 1 diabetes who received a therapy derived from stem…
STAT+: House panel weighs new plan for Medicare coverage of Wegovy, cancer blood tests
WASHINGTON — A House panel is exploring holding a vote on scaled-back versions of two…
‘We’re failing right now’ in type 2 diabetes, FDA chief says
ORLANDO — The United States is at a critical juncture in its efforts to treat…
STAT+: Kaiser adds a small North Carolina health system to its Risant Health network
Kaiser Permanente on Friday announced the next deal to build out its Risant Health network…
STAT+: What the Sarepta decision means for Duchenne patients, the company, and the FDA
Sarepta Therapeutics always wins. That was a given, even before the Food and Drug Administration…